Only one person was conspicuously missing from the (American Society of Clinical Oncology, ASCO) party – Dennis Slamon. Having spent the afternoon planning the next phase of Herceptin trials with breast oncologists at ASCO, Slamon had jumped into his rundown Nissan and driven home.

Report Quote Report Quote Report Quote Submit Quote Submit Quote Submit Quote